Linda Sharp

17.1k total citations
449 papers, 11.3k citations indexed

About

Linda Sharp is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Linda Sharp has authored 449 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Oncology, 93 papers in Pulmonary and Respiratory Medicine and 75 papers in Epidemiology. Recurrent topics in Linda Sharp's work include Global Cancer Incidence and Screening (101 papers), Cancer survivorship and care (82 papers) and Colorectal Cancer Screening and Detection (80 papers). Linda Sharp is often cited by papers focused on Global Cancer Incidence and Screening (101 papers), Cancer survivorship and care (82 papers) and Colorectal Cancer Screening and Detection (80 papers). Linda Sharp collaborates with scholars based in United Kingdom, Ireland and United States. Linda Sharp's co-authors include Julian Little, Aileen Timmons, Paul Hanly, Harry Comber, Seonaidh Cotton, Kathleen Bennett, Thomas I. Barron, Anne‐Elie Carsin, Frances J. Drummond and Kala Visvanathan and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Linda Sharp

423 papers receiving 11.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Sharp United Kingdom 52 4.6k 1.9k 1.8k 1.6k 1.6k 449 11.3k
Timothy L. Lash United States 60 3.6k 0.8× 1.3k 0.7× 1.4k 0.8× 1.9k 1.2× 1.6k 1.1× 348 15.0k
Lisa C. Richardson United States 54 5.7k 1.2× 1.1k 0.6× 1.5k 0.8× 1.8k 1.1× 1.2k 0.8× 232 10.6k
Scarlett Lin Gomez United States 58 6.6k 1.4× 1.1k 0.6× 2.2k 1.2× 1.3k 0.8× 1.6k 1.0× 321 12.5k
Michel P. Coleman United Kingdom 61 6.7k 1.5× 2.0k 1.0× 2.2k 1.2× 2.0k 1.2× 1.4k 0.9× 291 13.3k
Linda C. Harlan United States 52 4.6k 1.0× 1.7k 0.9× 2.8k 1.6× 1.1k 0.6× 1.9k 1.2× 118 10.7k
Wendy R. Parulekar Canada 30 5.2k 1.1× 2.3k 1.2× 3.1k 1.7× 1.5k 0.9× 1.3k 0.9× 131 14.9k
Vilma Cokkinides United States 49 7.7k 1.7× 1.3k 0.7× 2.6k 1.4× 2.5k 1.5× 1.5k 1.0× 75 14.0k
Chien‐Wen Tseng United States 58 3.5k 0.8× 1.8k 0.9× 2.4k 1.3× 2.8k 1.7× 2.4k 1.5× 130 14.8k
Paul W. Dickman Sweden 59 4.0k 0.9× 2.1k 1.1× 1.8k 1.0× 1.4k 0.9× 1.4k 0.9× 198 12.5k
Allison M. Deal United States 53 4.8k 1.0× 1.7k 0.9× 2.2k 1.2× 625 0.4× 1.9k 1.2× 403 10.7k

Countries citing papers authored by Linda Sharp

Since Specialization
Citations

This map shows the geographic impact of Linda Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Sharp more than expected).

Fields of papers citing papers by Linda Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Sharp. The network helps show where Linda Sharp may publish in the future.

Co-authorship network of co-authors of Linda Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Sharp. A scholar is included among the top collaborators of Linda Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Sharp. Linda Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Wafaa, Linda Sharp, Christina Dobson, et al.. (2025). Endoscopic Retrograde Cholangiopancreatography (ERCP) services across the UK. Gut. 75(3). 437–441.
2.
Rutter, Matthew D., Peter McMeekin, Linda Sharp, et al.. (2024). Quantifying the cost savings and health impacts of improving colonoscopy quality: an economic evaluation. BMJ Quality & Safety. 34(7). 469–478. 2 indexed citations
3.
Greystoke, Alastair, et al.. (2024). Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study. Cancer Epidemiology Biomarkers & Prevention. 33(10). 1298–1310.
4.
Fuccio, Lorenzo, Colin Rees, Leonardo Frazzoni, et al.. (2023). Patient-reported experience of colonoscopy in Italy: a multicentre prospective observational study. Gut. 72(12). 2227–2230. 4 indexed citations
5.
Crowe, Lisa, Morven C. Brown, Alastair Greystoke, et al.. (2023). Assessing the unmet needs of patients with advanced cancer treated by biological and precision therapies: protocol for TARGET, a mixed methods study. BMJ Open. 13(5). e066229–e066229. 1 indexed citations
6.
McFerran, Ethna, James F. O’Mahony, Steffie K. Naber, et al.. (2022). Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?. MDM Policy & Practice. 7(1). 97843816–97843816. 6 indexed citations
7.
Azubuike, Samuel O., et al.. (2022). Physical activity and the risk of breast cancer among Nigerian women. Cancer Epidemiology. 78. 102163–102163. 4 indexed citations
8.
Hanly, Paul, et al.. (2021). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4). 580–593. 21 indexed citations
9.
Sharp, Linda, et al.. (2021). Using a dark logic model to explore adverse effects in audit and feedback: a qualitative study of gaming in colonoscopy. BMJ Quality & Safety. 31(10). 704–715. 19 indexed citations
10.
11.
Longo, Christopher J., Margaret I. Fitch, Laura Banfield, et al.. (2020). Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Supportive Care in Cancer. 28(10). 4645–4665. 94 indexed citations
12.
Torp, Steffen, et al.. (2019). Work Experiences During and After Treatment Among Self-Employed People with Cancer. Journal of Occupational Rehabilitation. 30(1). 49–58. 17 indexed citations
13.
O’Connor, Mairead, Jo Waller, Pamela Gallagher, et al.. (2016). Exploring women’s sensory experiences of undergoing colposcopy and related procedures: implications for preparatory sensory information provision. Journal of Psychosomatic Obstetrics & Gynecology. 37(4). 137–146. 5 indexed citations
14.
15.
Barron, Thomas I., Laura Murphy, Chris Brown, et al.. (2015). De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I–III Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 24(6). 898–904. 21 indexed citations
16.
Sharp, Linda, Joseph McDevitt, Anne‐Elie Carsin, Chris Brown, & Harry Comber. (2014). Smoking at Diagnosis Is an Independent Prognostic Factor for Cancer-Specific Survival in Head and Neck Cancer: Findings from a Large, Population-Based Study. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2579–2590. 75 indexed citations
17.
Spillane, Susan, Kathleen Bennett, Linda Sharp, & Thomas I. Barron. (2013). A Cohort Study of Metformin Exposure and Survival in Patients with Stage I–III Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 22(8). 1364–1373. 81 indexed citations
18.
Barron, Thomas I., Roisín M. Connolly, Linda Sharp, Kathleen Bennett, & Kala Visvanathan. (2011). Beta Blockers and Breast Cancer Mortality: A Population- Based Study. Journal of Clinical Oncology. 29(19). 2635–2644. 428 indexed citations
19.
Sharp, Linda, Julian Little, Nigel T. Brockton, et al.. (2002). Dietary intake of folate and related micronutrients, genetic polymorphisms in MTHFR and colorectal cancer A population-based case-control study in Scotland. Journal of Nutrition. 3542. 12 indexed citations
20.
Little, Julian, et al.. (2001). Burkitt’s Lymphoma: a review of the epidemiology. 33. 293–306. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy L. Lash Breakdown of academic impact, for papers by Lisa C. Richardson Breakdown of academic impact, for papers by Scarlett Lin Gomez Breakdown of academic impact, for papers by Michel P. Coleman Breakdown of academic impact, for papers by Linda C. Harlan Breakdown of academic impact, for papers by Wendy R. Parulekar Breakdown of academic impact, for papers by Vilma Cokkinides Breakdown of academic impact, for papers by Chien‐Wen Tseng Breakdown of academic impact, for papers by Paul W. Dickman Breakdown of academic impact, for papers by Allison M. Deal
Rankless by CCL
2026